Manager TitleAgeSince
Chief Executive Officer - 2024-03-12
Director TitleAgeSince
Director/Board Member - 2023-06-06
Director/Board Member - 2023-06-06
Date Insider Type Main position Quantity % Market Cap.
12/11/25 Other

Chief Executive Officer

0 -
12/11/25 Sell

Director

800,000 -
12/11/25 Other

Chief Executive Officer

0 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 8.49M
-1.35%-0.82%-10.59%-4.17% 13.44B
-2.94%-3.76%-31.42%-51.83% 5.08B
-0.78%+1.50%-1.38%-2.62% 4.8B
-3.19%-0.61%+1.11%-32.57% 4.05B
-2.43%-3.43%+0.94%-10.97% 3.63B
-1.33%+1.56%-2.63%-4.79% 3.63B
-1.19%+2.47%-3.08%+10.29% 3.48B
-2.28%-0.77%-14.27%-23.60% 2.4B
-3.10%-2.19%-5.97%+39.02% 1.82B
Average -1.86%-3.10%-7.48%-9.03% 4.7B
Weighted average by Cap. -1.86%-2.83%-8.65%-11.12%
Logo Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).
Employees
-